Ju, Feng, Weng, Jialei, Fan, Ningbo ORCID: 0000-0002-1622-6747, Wang, Zhefang ORCID: 0000-0002-2297-2586, Zhou, Chenghui ORCID: 0000-0003-1170-1761, Zhao, Xinlei, Horstmann, Nellie, Wu, Xiaolin ORCID: 0009-0006-3037-3328, Hoppe, Sascha, You, Bo ORCID: 0000-0002-3602-5264, Li, Keying, Duan, Jianxin, Odenthal, Margarete ORCID: 0000-0002-2424-0960, Hillmer, Axel M. ORCID: 0000-0002-3381-7266, Quaas, Alexander ORCID: 0000-0002-3537-6011, Bruns, Christiane J. ORCID: 0000-0001-6590-8181 and Zhao, Yue ORCID: 0000-0002-6790-3402 (2025). AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5. Cell Death & Disease, 16 (1). pp. 1-16. Springer Nature. ISSN 2041-4889

[thumbnail of s41419-025-07773-z.pdf] PDF
s41419-025-07773-z.pdf
Bereitstellung unter der CC-Lizenz: Creative Commons Attribution.

Download (10MB)
Identification Number:10.1038/s41419-025-07773-z

Abstract

[Artikel-Nr.: 483] Esophageal adenocarcinoma (EAC) is the predominant subtype of esophageal cancer (EC) in high-income countries, and radioresistance is one of the key factors for the poor prognosis. In this study, we successfully established a radioresistant EAC in vitro model. Aldo-keto reductase 1C3 (AKR1C3) was identified as a promising regulator of radioresistance by RNA-seq analysis and subsequent functional studies. Through integrated analyses of scRNA-seq and TCGA datasets, we found that AKR1C3 was likely to enhance radioresistance by inhibition of ferroptosis. Indeed, analysis of the lipid ROS level by C11-Bodipy staining and the result of transmission electron microscopy revealed that AKR1C3 could prevent EAC cells from ferroptosis. Mechanistically, AKR1C3 binds to the nucleotide-binding domain of HSPA5, thereby inhibiting the E3 ligase TRIM21-induced ubiquitin-dependent proteasomal degradation of HSPA5, which further stabilizes GPX4, thus inhibiting ferroptosis. Importantly, AKR1C3 inhibitor resensitized the EAC patient-derived organoids to radiotherapy. In conclusion, this study highlights AKR1C3 as a regulator of radioresistance and a potential therapeutic target in EAC.

Item Type: Article
Creators:
Creators
Email
ORCID
ORCID Put Code
Ju, Feng
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Weng, Jialei
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Fan, Ningbo
UNSPECIFIED
UNSPECIFIED
Wang, Zhefang
UNSPECIFIED
UNSPECIFIED
Zhou, Chenghui
papamamaiuhui@163.com
UNSPECIFIED
Zhao, Xinlei
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Horstmann, Nellie
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Wu, Xiaolin
UNSPECIFIED
UNSPECIFIED
Hoppe, Sascha
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
You, Bo
UNSPECIFIED
UNSPECIFIED
Li, Keying
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Duan, Jianxin
UNSPECIFIED
UNSPECIFIED
UNSPECIFIED
Odenthal, Margarete
UNSPECIFIED
UNSPECIFIED
Hillmer, Axel M.
UNSPECIFIED
UNSPECIFIED
Quaas, Alexander
UNSPECIFIED
UNSPECIFIED
Bruns, Christiane J.
UNSPECIFIED
UNSPECIFIED
Zhao, Yue
UNSPECIFIED
UNSPECIFIED
URN: urn:nbn:de:hbz:38-801534
Identification Number: 10.1038/s41419-025-07773-z
Journal or Publication Title: Cell Death & Disease
Volume: 16
Number: 1
Page Range: pp. 1-16
Number of Pages: 16
Date: 2 July 2025
Publisher: Springer Nature
ISSN: 2041-4889
Language: English
Faculty: Faculty of Medicine
Divisions: Faculty of Medicine > Chirurgie > Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und Transplantationschirurgie
Subjects: Medical sciences Medicine
['eprint_fieldname_oa_funders' not defined]: Publikationsfonds UzK
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/80153

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item